The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
Emerging Markets Growth Fund R-6 REFGX
- NAV / 1-Day Return 6.91 / +0.88 %
- Total Assets 1.4 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.730%
- Distribution Fee Level Low
- Share Class Type Retirement, Large
- Category Diversified Emerging Mkts
- Investment Style Large Growth
- Min. Initial Investment 1.0 Mil
- Status Open
- TTM Yield 1.44%
- Turnover 38%
USD | NAV as of Jul 05, 2024 | 1-Day Return as of Jul 05, 2024, 10:22 PM GMT+0
Morningstar’s Analysis REFGX
Will REFGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 6.68 | 92.4 Mil | Technology |
Cash & Cash Equivalents | 3.26 | 45.1 Mil | Cash and Equivalents |
Innovent Biologics Inc | 2.83 | 39.2 Mil | Healthcare |
BeiGene Ltd ADR | 2.78 | 38.4 Mil | Healthcare |
Ping An Insurance (Group) Co. of China Ltd Class H | 2.72 | 37.5 Mil | Financial Services |
Jiangsu Hengrui Pharmaceuticals Co Ltd Class A | 2.65 | 36.6 Mil | Healthcare |
NetEase Inc Ordinary Shares | 2.56 | 35.4 Mil | Communication Services |
MakeMyTrip Ltd | 2.54 | 35.1 Mil | Consumer Cyclical |
Trip.com Group Ltd ADR | 2.12 | 29.3 Mil | Consumer Cyclical |
PT Bank Syariah Indonesia Tbk Ordinary Shares | 2.03 | 28.1 Mil | Financial Services |